BridgeMD
New treatment option for HIV Infection
Official title Impact of Mediterranean Diet in Cardiovascular Risk Among People With HIV
ClinicalTrials.gov ID: NCT06757309
What this study is testing
- What it's testing
- This study (VIHMET) aims to explore how dietary changes, specifically the adoption of a Mediterranean diet, can improve health outcomes in people living with HIV (PLWH) who are on antiretroviral therapy (ART). PLWH often experience chronic inflammation, metabolic disturbances, and elevated cardiovascular risk due to the virus, immune activation, and ART-related side effects.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older.
- Confirmed diagnosis of HIV infection.
- On stable antiretroviral therapy (ART) with an undetectable viral load for at least 12 months.
- LDL cholesterol levels \>140 mg/dL.
- Low adherence to the Mediterranean diet, defined by a MEDAS score \<9.
You likely can't join if
- Use of lipid-lowering medications.
- Chronic use of anti-inflammatory drugs.
- Active hepatitis B or hepatitis C infection.
- Other chronic inflammatory conditions (e.g., autoimmune diseases).
- Familial hypercholesterolemia.
- Uncontrolled metabolic conditions, such as hypothyroidism or diabetes mellitus.
See the full eligibility criteria
- Adults aged 18 years or older.
- Confirmed diagnosis of HIV infection.
- On stable antiretroviral therapy (ART) with an undetectable viral load for at least 12 months.
- LDL cholesterol levels \>140 mg/dL.
- Low adherence to the Mediterranean diet, defined by a MEDAS score \<9.
- Must be able to swallow tablets
- Willingness and ability to provide informed consent.
- Use of lipid-lowering medications.
- Chronic use of anti-inflammatory drugs.
- Active hepatitis B or hepatitis C infection.
- Other chronic inflammatory conditions (e.g., autoimmune diseases).
- Familial hypercholesterolemia.
- Uncontrolled metabolic conditions, such as hypothyroidism or diabetes mellitus.
- Pregnancy or breastfeeding.
- Cognitive or psychological conditions impairing the ability to comply with the study protocol.
- Inability to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.